Sfoglia per Rivista  DIGESTIVE DISEASES AND SCIENCES

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 10 a 24 di 24
Titolo Data di pubblicazione Autore(i) File
Is furazolidone therapy for Helicobacter pylori effective and safe? 1-gen-2009 De Francesco, V; Ierardi, E; Hassan, Cesare; Zullo, A.
Is POEM the Answer for Management of Spastic Esophageal Disorders? A Systematic Review and Meta-Analysis 1-gen-2017 Khan Muhammad, Ali; Kumbhari, Vivek; Ngamruengphong, Saowanee; Ismail, Amr; Chen, Yen-I; Chavez Yamile, Haito; Bukhari, Majidah; Nollan, Richard; Ismail Mohammad, Kashif; Onimaru, Manabu; Balassone, Valerio; Sharata, Ahmed; Swanstrom, Lee; Inoue, Haruhiro; Repici, A; Khashab Mouen, A.
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 1-gen-2015 Scaldaferri, F; Vetrano, S
Methotrexate for primary biliary cirrhosis : who is to be trusted? 1-gen-2010 Selmi, C.; Podda, M.
New method for improving accuracy of 24-hour continuous intragastric pH-metry. Reflections on physiological and pharmacological studies 1-gen-1994 Mela, G. S.; Savarino, V.; Malesci, A.; Di Mario, F.; Sossai, P.; Vigneri, S.; Zambotti, A.
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis c (case study and literature review) 1-gen-2014 Fabrizi, F.; Aghemo, A.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Martin, P.; Messa, P.
Predictive Narrow-Band Imaging of Colonic Polyps: The Optics Are Good 1-gen-2018 Paggi, Silvia; Hassan, C; Radaelli, Franco
Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection. 1-gen-2004 Pellicano, R; Touscoz, Ga; Smedile, A; Berrutti, M; Saracco, G; Repici, A; Ponzetto, A; Rizzetto, M
Risk of pancreatic cancer associated with cholelithiasis, cholecystectomy, or gastrectomy 1-gen-1996 Gullo, L.; Pezzilli, R.; Morselli-Labate, A. M.; Casadei, R.; Campione, O.; Brambati, M.; Lesi, C.; Andriulli, A.; Acquadro, P.; D'Ambrosi, A.; Alvisi, V.; Montalto, G.; Carroccio, A.; De Conca, V.; Mornese, A.; Mansi, C.; Malesci, A.; Zerbi, A.; Battistini, C.; Sperti, C.; Pasquali, C.; Gaeta, L.; Felder, M.
Serum markers of immune activation and liver allograft rejection 1-gen-1992 Lalli, E; Meliconi, R; Conte, R; Mancini, A; Uguccioni, M; Stefanini, Gf; Gasbarrini, G
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection 1-gen-1999 Cammarota, G; Cannizzaro, O; Cianci, R; Armuzzi, A; Gasbarrini, A; Pastorelli, A; Papa, A; Gasbarrini, G
Time pattern of gastric acidity in Barrett's esophagus 1-gen-1996 Savarino, V.; Mela, G. S.; Zentilin, P.; Mele, M. R.; Mansi, C.; Remagnino, A. C.; Vigneri, S.; Malesci, A.; Belicchi, M.; Lapertosa, G.; Celle, G.
Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"? 1-gen-2019 Le Berre, C; Danese, S; Peyrin-Biroulet, L
Tumour necrosis factor alpha in segmental colitis associated with diverticula 1-gen-2008 Ierardi, E; Meucci, G; Hassan, Cesare; Zullo, A; Imperiali, G; De Francesco, V; Panella, C; Morini, S; Minoli, G.
Understanding the Role of PNPLA3 Genetic Variants in Patients with Chronic Hepatitis C Infection 1-gen-2012 Aghemo, A
Mostrati risultati da 10 a 24 di 24
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile